Announcements Trials
Browse Landscape

Phase

Phase 2 2

Status

Terminated 1Active not recruiting 1

Sponsor Class

OTHER 2

Study Type

Interventional 2

Sponsor

Cancer Type

Gastrointestinal 1

Conditions

Weight Loss 2Anorexia 2Pancreatic Neoplasms 1Neoplasm Metastasis 1Lung Neoplasms 1Carcinoma, Non-Small-Cell Lung 1Cachexia 1

Interventions

anamorelin 2Caloric Restriction 2Urine Specimen Collection 1Tirzepatide 1Sampling Studies 1Resistance Training 1Psychology, Positive 1Population Groups 1Olanzapine 1Nutrition Assessment 1Mirtazapine 1Methods 1Metformin 1Megestrol Acetate 1Inositol 1Growth Differentiation Factor 15 1Diet, Reducing 1Diet Therapy 1Diet 1Counseling 1Cognitive Behavioral Therapy 1Breast Implants 1Blood Specimen Collection 1Biopsy 12,2,2',4'-tetrachloroacetophenone 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Weight Loss × anamorelin × 1 year × Clear all
NCT04844970 2025-11-17

Anamorelin Study for Advanced Pancreatic Cancer

Lahey Clinic

Phase 2 Terminated
4 enrolled 12 charts
Gastrointestinal

Anorexia, Cachexia, Pancreatic Neoplasms, Weight Loss

NCT03035409 2025-11-10

Anamorelin Hydrochloride, Physical Activity, and Nutritional Counseling in Decreasing Cancer-Related Fatigue in Patients With Incurable Metastatic or Recurrent Solid Tumors

M.D. Anderson Cancer Center

Phase 2 Active not recruiting
129 enrolled 11 charts

Neoplasm Metastasis, Weight Loss

Data powered by HemOnc (CC BY 4.0) Colophon âš¡